Skip to main content
OpenTrials

Clinical trial condition

Nephritis

Explore clinical trials studying Nephritis. Study availability and eligibility vary by location and protocol.

616 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Nephritis trial results

Active, Not Recruiting

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

NCT06255028

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +27 more
Locations
  • Keck School of Medicine of University of Southern California Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Lurie Children's; Northwestern Medicine - Northwestern Medical Group Chicago, Illinois, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of Telitacicept for IgA Nephropathy (TELIGAN)

NCT05799287

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
View all 101 locations
View Trial Details
Active, Not Recruiting

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

NCT06265220

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Artiva Investigational Site Birmingham Birmingham, Alabama, United States
  • Artiva Investigational Site Tucson Tucson, Arizona, United States
  • Artiva Investigational Site San Diego San Diego, California, United States
  • Artiva Investigational Site Aventura Aventura, Florida, United States
View Trial Details
Active, Not Recruiting

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

NCT06294236

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +33 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT06342960

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Charite- Universitätsklinikum Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details
Active, Not Recruiting

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT05938725

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Massachusetts Worcester Worcester, Massachusetts, United States
  • Northwell Health Great Neck, New York, United States
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

NCT05732402

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
Locations
  • Investigational Site (523) Phoenix, Arizona, United States
  • Investigational Site (501) Phoenix, Arizona, United States
  • Investigational Site (524) Tucson, Arizona, United States
  • Investigational Site (506) Valencia, California, United States
View all 30 locations
View Trial Details

Related conditions